Intracranial pressure (ICP) was recorded continuously in chronically prepared, unanesthetized cats in order to investigate the effects on ICP of the cholinergic agonist, carbamylcholine (carbachol), injected by microsyringe needles into the dorsal pontine tegmentum. As reported previously, carbachol microinjections into the medial part of the cholinoceptive pontine inhibitory area (CPIA) located ventromedially to the locus coeruleus produced a comatose state characterized by a profound unresponsiveness to external stimuli, desynchronized electroencephalograms (EEG's), and suppression of postural somatomotor and sympathetic visceromotor functions. Four of six ICP records following carbachol microinjections into the CPIA showed small but significant increases which occurred in association with these carbachol effects. Tracings of ICP increases ranged up to 3.2 mm Hg and were similar in shape to plateau waves. The start and resolution of these carbachol-induced ICP variations were closely associated with the onset and termination of EEG desynchronization and signs of reduced cervical sympathetic tone, but not with changes in systemic arterial blood pressure or arterial pCO2. Temporal associations between ICP increases, desynchronized EEG's, and signs of reduced sympathetic tone were repeatedly confirmed during recovery periods associated both with recurrent comatose states following wakefulness produced by various intensities of external stimulation and with spontaneously occurring states resembling rapid eye movement sleep. The authors infer that carbachol-induced ICP variations may be produced by increased cerebral blood volume in response to accelerated cerebral metabolism and reduced vasoconstrictor tone of cervical sympathetic nerves. The simultaneous occurrence of continuously accelerated cerebral metabolism and reduced cervical sympathetic tone can neither be seen in physiologically normal, awake organisms nor produced by other known experimental manipulations of the central nervous system. Such a paradoxical relationship appears to be a unique consequence of activity within the CPIA. These data suggest that episodic activity within the CPIA may provide at least one endogenous neural basis for plateau waves seen during certain pathological conditions such as disturbed cerebrospinal fluid (CSF) absorption or with reduced equilibrium volume of CSF space. KEY WORDS 9 carbachol 9 intracranial pressure 9 cholinergic system 9 plateau wave 9 pontine tegmentum 9 sympathetic nerve 9 cat S PONTANEOUS episodic elevations of intracranial pressure (ICP), termed "plateau waves, "32'33 are a well known phenomenon observed in patients with intracranial mass lesions or hydrocephalus. Since plateau waves can occur spontaneously, 32'33 certain endogenous processes may underlie their occurrence. Furthermore, since plateau waves do not occur in patients with severe damage to the brain, 6'32'33 such endogenous processes may originate from the episodic changes in activity of certain neural functions. 9'3~ It has repeatedly been reported that plateau waves occur in association with rapid eye movement (REM) sleep, 7'8"12'13'41'47'49'62 or at least in association with signs similar to certain components of REM sleep. 6'9,3~ Thus, neural mechanisms of REM sleep may involve episodic activity of at least one endogenous neural function associated with processes underlying plateau waves.
S
PONTANEOUS episodic elevations of intracranial pressure (ICP), termed "plateau waves, "32'33 are a well known phenomenon observed in patients with intracranial mass lesions or hydrocephalus. Since plateau waves can occur spontaneously, 32'33 certain endogenous processes may underlie their occurrence. Furthermore, since plateau waves do not occur in patients with severe damage to the brain, 6'32'33 such endogenous processes may originate from the episodic changes in activity of certain neural functions. 9'3~ It has repeatedly been reported that plateau waves occur in association with rapid eye movement (REM) sleep, 7'8"12'13'41 '47'49 '62 or at least in association with signs similar to certain components of REM sleep. 6'9,3~ Thus, neural mechanisms of REM sleep may involve episodic activity of at least one endogenous neural function associated with processes underlying plateau waves.
The neural mechanisms of REM sleep appear to involve activity associated with the pontine tegmentum. 17'23 '37 In addition, cholinergic systems have been reported to mediate REM sleep. 23'6~ Of particular interest is the observation that microinjections ofcholinergic agonists into the pontine tegmentum can produce various components of REM sleep separately or in combinations. LH' 59 We have recently conducted a systematic study exploring the effects of the cholinergic agonist, carbamylcholine hydrochloride (carbachol), microinjected into the various areas of the pontine tegmentum. We found that cholinergic activation of an area ventromedial to the principal nucleus of the locus coeruleus can produce maximal suppression of postural somatomotor and sympathetic visceromotor functions, disruption of orienting behaviors, and desynchronization of electroencephalograms (EEG's) in chronically prepared, unanesthetized cats. 25 This area contains cholinergic and cholinoceptive neurons 28 and belongs to a medial part of the cholinoceptive pontine inhibitory area (CPIA), from which suppression of various aspects of the organisms' responsiveness to external stimuli is observed following cholinergic activation. 25' 27 All of the carbachol effects observed in the medial part of the CPIA resemble certain components of REM sleep. However, the effects on experimental animals were so pronounced that, unlike animals in naturally occurring REM sleep, they appeared comatose and were not arousable even by noxious stimuli for several minutes following carbachol microinjections (Y Katayama, et al., in preparation, 1984) . Recent studies have also demonstrated that lesions placed in this region of the cat release postural muscle tone and orienting behaviors during REM sleep. 15' t6' 37' 38 Thus, cats with such lesions can stand and walk around even though they are in REM sleep.
These observations indicate that activity of the medial part of the CPIA may be responsible for certain components of REM sleep. Recently, it has been reported that ICP variations smaller in amplitude but similar in shape to plateau waves can be seen during REM sleep even in the normal monkey. ~2'3 Thus, in the present study, we have investigated whether or not the medial part of the CPIA is involved in mechanisms underlying such ICP variations in the normal, chronically prepared, unanesthetized cat. In addition, this research incorporated detailed characterizations of temporal relationships between ICP variations and other consequences of activation of the medial part of the CPIA. The results indicate that episodic activity within the CPIA may be at least one endogenous neural basis of plateau waves under certain pathological conditions.
Materials and Methods

Surgical Preparation for Chronic Experiments
This study employed seven adult cats, weighing 2 to 4 kg each. All cats were surgically prepared under general anesthesia (intravenous sodium pentobarbital, 30 mg/kg) and aseptic conditions. Two No. 26 guide tubes (30 mm in length) were implanted symmetrically through the cerebellum, and permanently secured to the skull with dental acrylic and stainless steel screws. Guide tubes were placed to allow microinjections of Y. Katayama, et al.
drugs into the medial part of the C!'IA (P 2.0-3.0, L 1.5-2.0, H 2.5-3.5) and surrounding structures. 25 An angle of 45~ from the coronal plane was used to implant these guide tubes to avoid the tentorial bone. In addition, No. 20 guide tubes (10 mm in length) were implanted on the surface of the dura for later placement of needles for cerebrospinal fluid (CSF) pressure recordings. Procedures for placement of needles in the lateral ventricle or the cisterna magna of unanesthetized animals have been reported previously. 26' 48 Guide tubes were plugged with stylets when not in use. Stainless steel screws for recording EEG's were affixed to the skull in the parietal and occipital regions. Flexible wires for recording electromyograms (EMG's) were implanted in the nuchal muscles. Six additional stainless steel screws were placed on appropriate areas of the skull. Guide tubes were then secured to the skull and screws by a mass of dental acrylic. Finally, four horizontal indentations were drilled symmetrically into the mass of dental acrylic so that stereotaxic ear bars could be inserted into them to restrain the head securely.
Sequence of Experiments
Intracranial pressure was recorded following at least 1 week of postoperative recovery. During ICP recordings, the animal's head was attached to a stereotaxic frame by four ear bars held in place within the indentations of dental acrylic. Ear bars were fixed to the stereotaxic frame by the base of the stereotaxic holder. Since there were no pressure points applied to the animal, this procedure accomplished painless fixation of the head.
The following procedures promoted the absence of excessive movements by cats during experimental sessions: 1) nonaggressive cats were selected; 2) each animal was restrained in a loose-fitting canvas bag from which only its head protruded (nonaggressive cats were easily habituated to the canvas bag: placement of the animal's body in a wooden box together with bag restraint was also helpful, but usually not necessary); 3) animals were habituated to the restraint situation before actual recordings were carried out (habituation once a day for 3 days usually ensured satisfactory results); 4) animals were fed before each habituation and/or recording; and 5) animals were kept slightly warm during the restraint situation. Well habituated animals rarely struggled. Isolation of the animal within a sound-attenuation box was also occasionally helpful. Repeated ICP recordings were separated by at least 7 days in order to obviate potential CSF leakage from penetration sites of the dura. Habituation procedures were repeated during the period between recording sessions.
ICP Recording Procedures
The No. 25 needles were inserted into the lateral ventricle or the cisterna magna through previously implanted guide tubes. Placement of ventricular needles in the lateral ventricle was accomplished by the conven-tional method of monitoring resistance at the tip of the needle while a small amount of saline was continuously infused (5 ug/min). The ICP was monitored by strain gauge transducer and recorded on eight-channel polygraphs.* Additional procedures for ICP recording in unanesthetized cats have been described elsewhere. 26
Microinjection Procedures
Injection cannulas were constructed from No. 33 tubes (200 ~ in outer diameter, 100 ~ in inner diameter), and connected to lengths of PE 20 polyethylene tubing which were fitted to needles ofmicrosyringes.t Injection cannulas were then placed through previously implanted guide tubes. Solutions of the cholinergic agonist, carbachol, or an equal volume of saline were microinjected bilaterally through the left and right cannulas sequentially. In an effort to minimize the mass of neural tissue affected by the microinjections, a small unilateral dose and volume (1.0 ug in 0.5 ul, 0.9% saline vehicle) were used. The drug was infused at a constant rate of 0.5 ~l/min. Injection cannulas were left in place for an additional 2 minutes to minimize backflow of drugs when they were withdrawn. Carbachol microinjections, each separated by 7 days, were made at different depths along the cannula tracks in 1.0-mm increments up to 3.0 mm beyond the tips of guide tubes, using injection cannulas of different lengths (31, 32, and 33 mm). Detailed procedures for microinjections have been described elsewhere. 25,27
Physiological Recordings
Parietal and occipital EEG's, nuchal EMG's, and electro-oculograms (EOG's) were simultaneously monitored. The EOG's were recorded bipolarly by hypodermic needles placed on the lateral and medial edges of the orbit. The cervical sympathetic tone was inferred by monitoring of the resting width of the nictitating membranes. Unlike dually innervated visceral organs, smooth muscles of the nictitating membranes in the cat are exclusively innervated by the cervical sympathetic nerves. 55 Thus, nictitating membrane width in the cat has been used as a unique indicator of cervical sympathetic nerve activity. 55,56 Signals were amplified~ and recorded on an eight-channel polygraph. In addition, pupil size and palpebral width were noted. Criteria for reduced cervical sympathetic tone in the present study included fully relaxed nictitating membranes, fully constricted pupils, and loss of palpebral tone.
In the final experimental sessions of two animals, systemic arterial blood pressure (SAP) and heart rate were monitored by strain gauge transducer via a catheter previously implanted in the femoral artery. Wounds were repeatedly lavaged with 1% lidocaine hydrochloride. Arterial pOe, pCO2, and pH were frequently analyzed by a blood gas analyzer,w especially when the resting level of ICP changed.
Histological Confirmation
At the end of the experiment, animals were anesthetized with intravenous pentobarbital (40 mg/kg), microinjected with india ink (0.1 ul) through cannulas at predetermined depths, and then transcardially perfused with a 10% buffered formalin solution for subsequent histological confirmation of cannula placement. Only those observations obtained from paired injection sites showing less than 0.3 mm asymmetry, as confirmed histologically, were included in this analysis. We have employed the nomenclature defined by Berman 5 in the present study.
Statistical Analysis
Student's paired t-tests were used for parametric analyses. Variability is always expressed as the standard error of the mean.
Results
Of 14 bilateral symmetrical injection sites, six were in an area ventromedial to the locus coeruleus (the medial part of the CPIA, Fig. 1 ), three were in the periaqueductal gray matter of the rostral pons, three were in the central tegmental field of the mesencephalon, and two were in central aspects of the gigantocellular tegmental field of the pons. Although no clear boundary can be drawn between the CPIA, as determined physiologically by the maximal behavioral ef- During placements of microinjection cannulas through guide tubes (a and b), synchronization of EEG was blocked and respiratory rates were accelerated. Thereafter, the animal again showed intermittent synchronized EEG. The ICP level was stable and unaffected by cannula placements into the pontine tegmentum. B: Immediately before and after carbachol microinjection into the cholinoceptive pontine inhibitory area. During infusion of drugs, body movements and accelerated respiratory rate were seen. These are simply responses to environmental stimuli associated with the microinjection procedures. Within 4 minutes after the start of drug infusion, continuous desynchronization of EEG (c, also compare faster EEG traces of A and B) and disappearance of tonic EMG activity (d, also compare faster EMG traces of A and B) occurred. At the same time, profound relaxation of nictitating membranes was observed. Note that ICP also started to increase at the same time (e) and reached a new equilibrium level after approximately 50 seconds. C: Ten minutes after carbachol microinjection. Desynchronized EEG and absence of tonic EMG activity continued. Eye movements similar to rapid eye movements in sleep were not seen continuously. Nictitating membranes were also profoundly relaxed. The ICP was maintained at a higher equilibrium.
fects of carbachol, 25 and the gigantocellular tegmental field, as defined cytoarchitecturally, 5 the center of the gigantocellular tegmental field of the pons is located ventral to that of the CPIA.
Within 6 minutes following carbachol microinjections into the medial part of the CPIA, m a x i m u m carbachol effects were observed. Pupils became miotic, palpebrae were narrowed, nictitating membranes were fully relaxed, tonic nuchal E M G activity disappeared, and postural muscles became atonic. During the period of maximum carbachol effects, animals failed to show any postural motor responses or eye-opening responses (somatic palpebral and somatic nictitating membrane responses) even to noxious external stimuli. These carbachol effects were consistent with our previous observations, which can be summarized as suppression of sympathetic visceromotor and postural somatomotor functions and disruption of orienting behaviors (Y Katayama, et aL, in preparation, 1984). The onset of this carbachoMnduced comatose state was relatively abrupt and generally associated with the onset of low-voltage desynchronized EEG. However, sometimes it was difficult to determine with precision the onset of desynchronized EEG, especially if the EEG was desynchronized prior to the onset of carbachol effects. Usually, eye movements similar to those in REM sleep were not seen during the initial period following carbachol microinjections. These periods of maximum carbachol effect, during which animals were unresponsive to noxious external stimuli, were observed for approximately 10 minutes. Thereafter, although signs of reduced resting tone of sympathetic visceromotor and postural somatomotor functions continued unless animals were stimulated, animals gradually recovered from profound unresponsiveness to external stimuli. During this period, REM-like eye movements were seen if the cat was not stimulated. Four of six ICP records following carbachol microinjections into the medial part of the CPIA revealed that small but consistent increases in resting ICP occurred in association with the onset of the carbachoMnduced comatose state. This ICP increase was clearly seen if animals showed relatively synchronized EEG and stable ICP recordings prior to the onset of carbachol effects (Fig. 2) . The start of ICP increase coincided with EEG changes from relatively synchronized patterns to lowvoltage desynchronization, the disappearance of tonic nuchal EMG activity (Fig. 2B) , and the onset of signs of reduced cervical sympathetic tone. The ICP gradually increased over a time, ranging from 50 to 120 seconds (~ = 90.0 _ 15.4 sec), and reached a higher level of equilibrium. Thereafter, ICP stayed at this level ( Fig.  2B and C) . Increases in resting ICP, occurring in association with the maximum carbachol effects, varied from 0.7 to 1.8 mm Hg (R = 1.2 _ 0.2 mm Hg, p < O.Ol).
During the course of recovery from the maximal effects of carbachol microinjected into the medial part of the CPIA, animals passed through a state during which they could be transiently aroused behaviorally by various intensities of sudden external stimuli. In association with this transient behavioral arousal, ICP typically showed a relatively rapid decrease. Thereafter, animals again fell into a comatose state if left unstimulated. Simultaneously with reappearance of a comatose state, ICP increased again and reached levels previously associated with the carbachol-induced comatose state (Fig. 3A) . Thus, ICP variations associated with behavioral and EEG signs of carbachol-induced comatose states were repeatedly confirmed during these recovery periods (Fig. 3B ) in four of six ICP records following carbachol microinjections into the medial part of the CPIA.
Twenty typical samples of such ICP variations were studied using applications of various external stimuli at predetermined intervals varying from 30 seconds to 5 minutes. Animals were kept aroused by repeated stimulation. After stimulation ceased, animals became relaxed and frequently showed synchronized EEG. The start of ICP increases coincided with the onset ofdesynchronized EEG, disappearance of tonic nuchal EMG activity, and the onset of signs of reduced cervical sympathetic tone (Fig. 4) . Increase in ICP varied from 0.3 to 3.0 mm Hg (~ = 1.6 _+ 0.2 mm Hg, p < 0.01). Pulsation of ICP due to heart beats also increased (+23.8% _+ 6.3%, p < 0.01). Between 2 and 24 seconds (~ = 15.6 _+ 1.9 sec) after the start of ICP increase, REM-like eye movements occurred (Fig. 4) . The level of elevated ICP was maintained until the comatose state was interrupted by external stimuli, and 18 to 36 seconds (X = 23.7 + 1.4 sec) after external stimulation, the ICP dropped. In seven samples, SAP was monitored simultaneously with ICP: SAP showed slight decreases prior to the start of ICP increases (Figs. 3B and 4A ). These SAP decreases occurred during periods of EEG synchronization (Fig. 4A) . Thereafter, concomitant with the onset of desynchronized EEG and signs of reduced cervical sympathetic tone, SAP showed small but significant further reductions from 121.8 + 2.7 to 114.9 + 2.6 mm Hg (-5.7% + 0.4%, p < 0.01) in mean arterial blood pressure (Fig. 4B) . However, mean arterial blood pressure never dropped below 90 mm Hg. Furthermore, SAP decreases occurred only during the initial phase of ICP increases. Subsequently, SAP increased while ICP remained elevated (Figs. 3B and 4A and B). When external stimuli were applied, SAP showed biphasic changes (that is, transient decrease followed by moderate increase). Thereafter, SAP did not change while ICP returned to lower levels (Figs. 3B and 4A and C). Arterial pCO2 and pO2 were measured in four samples. No significant differences were seen between values prior to (pCO2, 33.8 + 1.2 mm Hg; pO2, 90.0 _+ 4.0 mm Hg) and during the carbachol-induced comatose state (pCO2, 34.8 _+ 1.2 mm Hg; pO2, 85.5 + 2.4 mm Hg).
Before animals had recovered completely from the effects of carbachol microinjected into the medial part of the CPIA, spontaneous episodic return of carbachol effects was frequently seen over the period of 6 hours after carbachol microinjections if animals were left unstimulated. These episodes were characterized by desynchronized EEG, disappearance of tonic nuchal EMG activity, REM sleep-like eye movements, and relaxation of nictitating membranes, and were typically preceded by synchronized EEG activity. Thus, these episodes mimicked naturally occurring REM sleep. Variations in ICP were again seen consistently in four o f six ICP records in association with this carbachol-induced REM sleep-like episode. Twenty-nine typical samples of such ICP variations were analyzed. The start of ICP increase precisely coincided with EEG changes from synchronization to desynchronization, disappearance of tonic nuchal EMG activity, and the onset of signs of reduced cervical sympathetic tone ( Fig.  5A and B) . Thereafter, ICP increased over periods varying from 16 to 40 seconds (~ = 25.5 ___ 1.1 sec) and reached a relatively constant level. Increases in ICP ranged from 0.5 to 3.2 mm Hg(~ = 1.8 _+ 0.1 mm Hg, p < 0.01). The ICP remained at this level as long as REM sleep-like states continued. Pulsation in ICP due to heart beats also increased in association with ICP increase (+33.3% ___ 6.3%, p < 0.01). In two ICP recordings, ICP pulsation due to heart beats increased gradually and progressively over 3 hours following carbachol microinjections. Between 3 and 29 seconds (~ = 12.2 ___ 1.2 sec) after the onset of ICP increase, REM sleep-like eye movements occurred (Fig. 5A and B) . At the spontaneous termination of REM sleep-like states, ICP decreased relatively rapidly and returned to baseline levels within 15 to 30 seconds (~ = 21.5 _+ 0.9 see). In contrast to the termination oflCP variations induced by external stimuli, ICP increases associated with REM sleep-like episodes terminated without preceding transient ICP increases in response to stimulation (compare Fig. 4A and C with Fig. 5A and C) . Thus, temporal associations between the resolution of ICP variations, and the termination of desynchronized EEG and signs of reduced cervical sympathetic tone were more clearly seen during REM sleep-like episodes (Fig. 5C ). In eight samples SAP was also monitored: it decreased slightly in association with EEG synchronization prior to the start of ICP increase (Fig. 5B) . Thereafter, concomitant with the onset of desynchronized EEG, and signs of reduced cervical sympathetic tone, SAP showed a small but significant further reduction from 112.1 ___ 2.0 to 105.0 ___ 2.0 mm Hg (-6.4% ___ 1.1%, p < 0.01) in mean arterial blood pressure ( Fig. 5A and B) . However, mean arterial blood pressure did not decrease below 90 mm Hg and was not maintained throughout the course of ICP increase (Fig. 5A and B) . At the time REM sleeplike states terminated, SAP sometimes transiently increased in association with behavioral wakefulness (Fig.  5A and C) . This increase in SAP did not correspond to the course of recovery of ICP level. Arterial pCO2 and pO2 were measured in four samples. No significant differences were seen between values prior to (pCO2, Before the start of an ICP increase, animals were wakeful but relaxed and often showed synchronized EEG. An ICP increase (g and o) started immediately after the spontaneous onset of desynchronized EEG (a and k), disappearance of tonic EMG activity (d and 1), and full relaxation of nictitating membranes (n, downward movement corresponds to relaxation). In contrast, eye movements similar to rapid eye movements (REM) in sleep were generally first seen on the ascending slope of ICP itacreases (f and m). A slight decrease in SAP preceded the ICP increase (i). Further decrease in SAP occurred concomitantly with relaxation of nictitating membranes (p). However, SAP returned to its previous level (j and q) while increase in ICP continued. When external stimuli were applied, startle responses were sometimes seen on the EEG and EMG traces (b and e). Next, ICP transiently increased in association with continued EEG desynchronization (b to c and r to s), reappearance of tonic EMG activity (e and t), voluntary eye movements, and retraction of nictitating membranes (u). Thereafter, ICP returned to previous levels (h and v), during which EEG was synchronized (c and s) and nictitating membranes were kept retracted. Note that, in contrast to REM sleep-like eye movements and SAP changes which did not closely parallel changes in ICP, the onset and termination of desynchronized EEG, disappearance of tonic EMG activity, and full relaxation of nictitating membranes closely coincided with the start and resolution oflCP increases. Microinjection of equal volumes of saline into the same sites from which carbachol-induced ICP variations were previously observed did not produce any consistent changes in ICP. In the remaining two of six ICP records following carbachol microinjections into the medial part of CPIA, no discernible ICP variations were observed, although the anatomical localization of injection sites did not differ from others. Behavioral and electrophysiological effects of carbachol in these two records were also identical to others. Carbachol microinjections into the periaqueductal gray matter or central tegmental field produced EEG desynchronization. However, such carbachol effects were never associated with ICP increases. These animals sometimes showed behavioral excitation and signs of increased sympathetic activity such as retraction of nictitating membranes and widening of pupils. Carbachol microinjections into the gigantocellular tegmental field produced carbachol effects similar to but less remarkable than those observed by carbachol microinjections into the medial part of the CPIA. Postural muscles became hypotonic but were responsive to external stimuli. Palpebrae and nictitating membranes were sometimes relaxed but were responsive to external stimuli. Changes in ICP were not seen consistently in association with the onset of these carbachol effects. However, small ICP variations similar to those described above were seen in association with REM sleep-like episodes in one of two ICP records following carbachol microinjections into the gigantocellular tegmental field of the pons.
Discussion
Aside from the amplitude of ICP increases, ICP variations observed in the present study and REM sleeprelated plateau waves reported previously share a number of similarities. First, the start of carbachol-induced ICP variations coincided with the onset of EEG desynchronization, disappearance of tonic nuchal EMG activity, and various signs of reduced cervical sympathetic tone. Coincidence of the start of ICP increase and EEG 6"7"12' 13 and EMG 6' 12' 49 changes, and signs of reduced sympathetic tone ~2' 13' 3~ have been reported in REM sleep-related plateau waves as well. Second, the maximum peak of ICP was reached within approximately 30 seconds following the onset of carbachol-induced ICP variations. The onset characteristics of this ascending slope of carbachol-induced ICP variations are similar to those reported in REM sleep-related plateau waves. 6'8'12"13'49'62 Third, eye movements similar to those in REM sleep, if they occurred at all, were usually observed after the onset of ICP increases. This temporal relationship between REM sleep-like eye movements and ICP variations is consistent with earlier observations that REM's begin after the onset of ICP increases and on the ascending slope of REM sleep-related plateau waves. 49 Fourth, after this initial period of ICP increase, ICP remained at a more or less constant level as long as REM sleep continued. This period of a constant ICP level is apparently an important characteristic of plateau waves. 32' 33' 62 Fifth, at the end of REM sleep, ICP decreased rapidly and returned to previous levels within approximately 20 seconds. All manifestations of REM sleep ended before ICP started to decrease, in agreement with previous reports concerning REM sleep-related plateau waves. 6-8,12,~ 3.42.49 Finally, the amplitude of ICP pulsations due to heart beats observed during carbachol-induced ICP increases were always, if only slightly, larger than pulsations observed in conjunction with resting ICP levels. The augmentation of ICP pulsation amplitude is a consistent observation in REM sleep-related plateau waves. 4, 7, 8, 49, 62 The cause of the gradual progressive increase in ICP pulsation amplitude following carbachol microinjections awaits further studies. In summary, morphological characteristics and associated physiological features of carbachol-induced ICP variations demonstrated in the present study are consistent with those of REM sleep-related plateau waves described in the previous reports. These consistencies strongly suggest that carbachol-induced ICP variations and REM sleep-related plateau waves may share common underlying mechanisms.
Several lines of observations indicate that ICP variations reported in this research did not result from changes in systemic physiological parameters. A decrease of arterial O2 saturation and an increase of CO2 in expired air have reportedly occurred during REM sleep? These changes produce dilatation of cerebral vessels, and thus could potentially contribute to ICP increases during REM sleep. However, these factors do not appear important for the production of carbacholinduced ICP variations since both arterial pO2 and pCO2 did not significantly change prior to and following the onset of ICP increases. 9,3~ Consequences of reduced sympathetic visceromotor tone observed in the present study included mild but significant decreases in SAP. Decreases in SAP may cause autoregulatory vasodilatation of cerebral vessels and thus increase ICP. 57 However, this is probably not the cause of carbachol-induced ICP variations since SAP decreases within the range observed in the present study may not produce large amounts of autoregulatory vasodilatation. 29 Moreover, ICP increases in the present study were seen in the absence of maintained SAP decreases. In carbachol-induced ICP variations observed during the recovery periods and REM sleep-like episodes, slight SAP decreases were seen only during the initial increasing phase of ICP variations but not during periods of maintained ICP increases. Since it is not likely that the transient slight SAP decrease produced the longer-lasting changes in ICP environment observed in the present study, this observation strongly suggests that the effects of reduced sympathetic visceromotor tone on SAP do not contribute significantly to the production of carbachol-induced ICP variations.
Many researchers have inferred that plateau waves result from an increase in cerebral blood volume (CBV). 7'8'32 '33'35'49'57'62 In fact, CBV increases have been reported during periods of plateau waves) 4 It has also been shown that CBV increases during periods of REM sleep. 53 Thus, it appears reasonable to assume that REM sleep-related plateau waves may also result from CBV increases. 7' 8' 49' 62 We also infer that carbachol-induced ICP variations observed in the present study may be due to CBV increases in response to increased rates of cerebral metabolism and reduced cerebral vasoconstrictor tone. We base this inference on two lines of evidence which are equally applicable to mechanisms of CBV increases during REM sleep. First, the start and resolution of ICP increases coincided well with the onset and termination of desynchronized EEG in carbacholinduced ICP variations and in REM-related plateau waves previously reported. 6' 7' 12,13 Desynchronized EEG is a state reflecting increased brain activity, which results in an increased rate of cerebral metabolism. 36 In fact, a significant increase in cerebral metabolism has been reported during REM sleep. 36's2 Thus, dilatation of cerebral vessels could result from increased cerebral metabolism during EEG desynchronization) 9' 2~ Second, the start and resolution of carbachol-induced ICP variations also coincided with the onset and termination of signs of reduced cervical sympathetic tone. Reduced sympathetic visceromotor tone is also one conspicuous feature of REM sleep) ~ A release from sympathetic tone dilates vessels in many organs. 58 In fact, vasodilatation in visceral organs has been reported during REM sleep. 51 Since smooth muscles in nictitating membranes are innervated exclusively by cervical sympathetic nerves, 55' 56 full relaxation of nictitating membranes observed in the present study indicates profound reduction of cervical sympathetic toneY TM Pupillary constriction and decreased palpebral tone may also be attributable to reduced cervical sympathetic tone. 25 Although influences of changes in sympathetic tone on different effector organs may not necessarily occur in conjunction with each other, it is possible that cerebral vasoconstrictor tone of cervical sympathetic nerves may also be reduced during carbachol-induced ICP variations.
The effectiveness of the sympathetic vasoconstrictor system for regulation of cerebral blood flow has not been well established? ~ It appears likely that, although experimental manipulations of sympathetic vasoconstrictor tone have a significant effect on the diameter of cerebral extraparenchymal vessels, 31' 58' 63 vasodilatory effects cannot be detected as .changes in cerebral blood flow because of the predominant role of metabolic factors in cerebral blood flow regulation. 5s It appears important to note that, to our best knowledge, cholinergic stimulation of the medial part of the CPIA may be the only known experimental manipulation of brain activity that could potentially produce simultaneous metabolic vasodilatation of cerebral vessels and reduced sympathetic visceromotor tone. For example, reduced sympathetic tone can be seen following lesions in various areas of the nervous system. 2~ '44 However, such manipulations are not likely also to produce increased brain activity. 39' 46 Increased brain activity can be produced by stimulation of various areas of the nervous system. 19,4~ However, such effects are accompanied by increased sympathetic tone as well. It is also likely that REM sleep is only one physiological event in normal organisms that produces continuously increased brain activity 36' 5~ and reduced sympathetic tone ~~ simultaneously. Desynchronization of EEG in the awake animal has been described as an EEG arousal reaction, 4~ and often accompanies increased sympathetic activities associated with a behavioral arousal reaction. 22 Thus, the paradoxical relationship between brain activity and sympathetic tone appears to be a unique feature of consequences of cholinergic stimulation of the CPIA and REM sleep. Although firm conclusions await further studies, it appears possible that such mechanisms may contribute to relatively pronounced vasodilatation of cerebral vessels and thus to CBV increases.
It is clear that CBV increases could generate longlasting ICP increases such as those seen in plateau waves if there is inadequate compensation for increased intracranial volume by changes in CSF volume. 54 Such a condition can be expected in patients with obstructive hydrocephalus in which the resistance to CSF absorption is increased, and in patients with intracranial mass lesions in which the compensatory CSF reserve is exhausted? 4 In addition, it is possible that, even with normal CSF absorption mechanisms, CBV increases may produce small but long,lasting ICP changes by reducing the equilibrium volume of CSF space. 6~ In view of clinical experience with intracranial mass lesions, it is reasonable to assume that the reduced equilibrium volume of the CSF space may be associated with an increase in equilibrium CSF pressure. Small ICP variations observed in the present study appear to be within a range in which such change in equilibrium ICP can occur even in normal animals. This possibility implies, in turn, that the amplitude of ICP variations in the presence of normal CSF absorption mechanisms may be related to the relative magnitude of changes in equilibrium volume of CSF space. Variation in the volume of the CSF space between individual animals could account for the observation that in some ICP records no discernible ICP variations were detected in association with carbachol microinjections into the CPIA. It is possible that, in contrast to normal individuals, the same CBV change can produce a larger change in equilibrium ICP in patients with a small CSF space due to an intracranial mass lesion, even without serious disturbances in CSF absorption. An earlier study 12"~3 has reported that ICP variations of 170.6 + 6.4 mm H20 (13.0 _+ 0.5 mm Hg) above the resting ICP levels occur during REM sleep in the normal monkey with intact CSF absorption mechanisms and normal CSF reserve for volume compensation. Although this earlier observation is in accordance with present data, the magnitude of ICP increases reported for the monkey is remarkably larger than ICP variations seen in the present study. It is our impression that this magnitude of long-lasting ICP increase may not occur physiologically in the normal cat.
The present study suggested that carbachol-induced ICP variations have a close temporal relationship with desynchronized EEG and reduced cervical sympathetic tone rather than with REM sleep-like eye movements themselves. The maximum initial effects of carbachol microinjection into the CPIA, in contrast to the effects of carbachol microinjection into the gigantocellular tegmental field of the pons, do not necessarily include production of REM sleep-like eye movements. Thus, carbachol microinjections into the CPIA may result in neural activity relatively specific to mechanisms underlying ICP variations. It has been reported that the start of plateau waves in general (that is, without REM itself) is also often associated with the onset ofdesynchronized EEG 6'18 and/or signs of reduced sympathetic visceromotor tone. 3~ Thus, it is possible that a paradoxical relationship between increased brain activity and reduced cervical sympathetic tone resulting from some neural dysfunction underlies the initiation of plateau waves. Secondary events related to elevated ICP, such as decreases in cerebral perfusion pressures and cerebral venous outflow, may contribute further to ICP increases. Pathophysiological activation or disinhibition of cells within the CPIA appears to be one potential mechanism for such consequences.
We have provided evidence of increased activity within the CPIA following concussive levels of fluidpercussion head injury in the catJ 4 Cholinergic stimulation of this area of the cat results in profound suppression of various aspects of behavioral responsiveness to external stimuli. 25' 27 Thus, animals appear comatose (Y Katayama, et al., in preparation, 1984) . Although further studies are clearly needed, there is a possibility that activity within the CPIA may, in certain instances, contribute to production of a comatose state and, at the same time, provide a neural basis of elevated ICP in conjunction either with disturbed CSF absorption or with reduced equilibrium volumes of the CSF space.
Summary
The present data suggest that episodic activity within the CPIA may provide at least one endogenous neural basis for spontaneous ICP variations. When CSF absorption is disturbed or the equilibrium volume of the CSF space is reduced, plateau waves may be produced by such endogenous neural activity in the brain stem. Secondary events related to elevated ICP, such as decreases in cerebral perfusion pressures and cerebral venous outflow, may contribute further to ICP increases on these occasions. Studies employing this model of ICP variation and experimental manipulations of CSF absorption or equilibrium volume of the CSF space may provide more detailed pathophysiological features of one form of plateau waves. In addition, it is possible that tonic, rather than episodic, activity within the CPIA may contribute to continuously elevated ICP in a certain group of comatose patients. Such a possibility warrants further investigation, which could lead to the development of rational therapeutic manipulations of neural activity for treatment of elevated ICP.
